Abiochem Biotechnology
Developing new biocatalysis and synthetic biology processes.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD251—376m (Dealroom.co estimates May 2021.)
Shanghai Shanghai (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Series A | ||
N/A | Series A | ||
$46.0m | Series C | ||
Total Funding | CAD62.7m |
Related Content
Recent News about Abiochem Biotechnology
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.